Skip to main content

This job has expired

You will need to login before you can apply for a job.

Process Development (PD) Engineer/Scientist

Employer
Molecular Templates, Inc.
Location
Austin, TX, USA
Start date
May 26, 2019

View more

Job Details

Company Description:

Molecular Templates (MTEM) is a clinical stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary Engineered Toxin Body (ETB)platform. MTEM's first immunotoxin, MT-3724, is in clinical development for non-Hodgkin's lymphoma. Pipeline products for additional oncology targets are being advanced toward clinical development. For more information, please visit MTEM's website at www.mtem.com.

Position Overview:

Molecular Templates is seeking a highly-skilled and highly-motivated professional to support optimization and transfer of novel protein-based therapeutics to manufacturing activities. The PD Engineer will be responsible for designing and implementing the manufacturing process and procedure from laboratory up to manufacturing scale-up; developing methods for production, purification, fermentation and testing of new process formulas, technologies and products. This includes new product scale-up, purification, process optimization, technology transfer and process validation activities, as well as developing production procedures and product specifications. This position will require excellent technical, analytical and problem-solving skills, along with ability to operate independently on progressively more complex activities and projects.

Job Responsibilities will include:
  • Develop methods for production, purification, fermentation and testing of new process formulas, technologies and products, including but not limited to: new product scale-up, protein purification, microbial fermentation, process optimization, analytical characterization, technology transfer and process validation activities and development of production procedures and product specifications
  • Establish operating equipment specifications to improve manufacturing techniques
  • Maintain knowledge of scientific trends and industry processes through readings, conferences and seminars; review literature to enhance or improve manufacturing procedures and methods. Use professional concepts and company policies and procedures to solve a wide range of difficult problems in creative and practical ways
  • May participate in the development of patent applications or regulatory documentation
  • Other duties and special projects, as assigned

Qualifications:
  • Advance Degree from accredited institution in life sciences, chemical engineering, biochemical engineering or related relevant field
  • Minimum of two (2) years of relevant industry experience
  • Demonstrated technical proficiency in biologic drug substance processes
  • Proven experience with protein expression, purification, formulation development and/or engineering, required
  • Excellent written and verbal communication skills
  • Excellent computer skills
  • Excellent analytical skills and problem-solving skills
  • Excellent organizational, time management, and multi-tasking skills
  • Ability to maintain highest standards of accuracy and attention to detail
  • Ability to function independently and exercise good judgement, as well as provide thought leadership
  • Ability to identify problems and solutions then act to resolve

Reporting Structure:

This position currently has no supervisory responsibilities. This position reports to Sr. Director, Process Development.

Molecular Templates, Inc. is an Equal Opportunity Employer and offers competitive salaries and benefits.

Molecular Templates Inc https://mtem.isolvedhire.com

Company

Molecular Templates, Inc. (MTEM) is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform with unique mechanisms of actions which are highly differentiated from antibody drug conjugates (ADCs). MTEM is developing MT-6402, which is in a Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients; MT-5111, which is in a Phase I clinical trial for the treatment of HER2-positive cancers; and MT-0169, which is in a Phase I clinical trial to treat relapsed/refractory myeloma. Additional preclinical compounds derived from our ETB platform technology are being advanced toward clinical development.  Additional information about MTEM can be obtained at www.mtem.com.  

OWNERSHIP: Public

STOCK SYMBOL: MTEM

STOCK EXCHANGE: NASDAQ

Company info
Website
Phone
512-869-1555
Location
9301 Amberglen Blvd, Ste 100
Austin
TX
78729
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert